Gerald R. Ewoldt

Array ( [id] => 6361709 [patent_doc_number] => 20100087630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'Use of XCR1 for Diagnosing or Monitoring of Immune Tolerance' [patent_app_type] => utility [patent_app_number] => 11/884944 [patent_app_country] => US [patent_app_date] => 2006-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 15385 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20100087630.pdf [firstpage_image] =>[orig_patent_app_number] => 11884944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4751947 [patent_doc_number] => 20080160020 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Methods For Reducing the Symptoms of Autoimmunity and Inflammation Using Binding Proteins Against Antigens Exposed on Dead or Dying Cells' [patent_app_type] => utility [patent_app_number] => 11/883873 [patent_app_country] => US [patent_app_date] => 2006-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16601 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20080160020.pdf [firstpage_image] =>[orig_patent_app_number] => 11883873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4663084 [patent_doc_number] => 20080253991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Anti-T Cell and Autoantigen Treatment of Autoimmune Disease' [patent_app_type] => utility [patent_app_number] => 11/815359 [patent_app_country] => US [patent_app_date] => 2006-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 13872 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20080253991.pdf [firstpage_image] =>[orig_patent_app_number] => 11815359 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4476516 [patent_doc_number] => 07906291 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-15 [patent_title] => 'Method for diagnosing multiple sclerosis' [patent_app_type] => utility [patent_app_number] => 11/345190 [patent_app_country] => US [patent_app_date] => 2006-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 5 [patent_no_of_words] => 11308 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/906/07906291.pdf [firstpage_image] =>[orig_patent_app_number] => 11345190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5290900 [patent_doc_number] => 20090023630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Methods and Means for Use in Diagnostics and Treatment of Diabetes' [patent_app_type] => utility [patent_app_number] => 11/883417 [patent_app_country] => US [patent_app_date] => 2006-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7857 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023630.pdf [firstpage_image] =>[orig_patent_app_number] => 11883417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4892973 [patent_doc_number] => 20080102071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-01 [patent_title] => 'T cell inhibitory receptor compositions and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/339066 [patent_app_country] => US [patent_app_date] => 2006-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13087 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20080102071.pdf [firstpage_image] =>[orig_patent_app_number] => 11339066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4675633 [patent_doc_number] => 20080213262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Inhibition of Islet Amyloid Polypeptide (Iapp) Aggregation for the Treatment of Type 2 Diabetes' [patent_app_type] => utility [patent_app_number] => 11/883010 [patent_app_country] => US [patent_app_date] => 2006-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10189 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213262.pdf [firstpage_image] =>[orig_patent_app_number] => 11883010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5887608 [patent_doc_number] => 20060275288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'GLP-1 receptor agonist and allosteric modulator monoclonal antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/335387 [patent_app_country] => US [patent_app_date] => 2006-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 23905 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275288.pdf [firstpage_image] =>[orig_patent_app_number] => 11335387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5502180 [patent_doc_number] => 20090162868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'Gene Markers and Utilization of the Same' [patent_app_type] => utility [patent_app_number] => 11/795225 [patent_app_country] => US [patent_app_date] => 2006-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8215 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162868.pdf [firstpage_image] =>[orig_patent_app_number] => 11795225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5776336 [patent_doc_number] => 20060104976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Identification and use of high efficacy vaccine antigens which modulate antigen presenting cells' [patent_app_type] => utility [patent_app_number] => 11/315081 [patent_app_country] => US [patent_app_date] => 2005-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14109 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20060104976.pdf [firstpage_image] =>[orig_patent_app_number] => 11315081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5236037 [patent_doc_number] => 20070128193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'GLP-1 agonists, compositions, methods and uses' [patent_app_type] => utility [patent_app_number] => 11/315728 [patent_app_country] => US [patent_app_date] => 2005-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 42 [patent_no_of_words] => 39767 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20070128193.pdf [firstpage_image] =>[orig_patent_app_number] => 11315728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6251836 [patent_doc_number] => 20100028326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'DIAGNOSIS OF HYPERINSULINEMIA AND TYPE II DIABETES AND PROTECTION AGAINST SAME BASED ON PROTEINS DIFFERENTIALLY EXPRESSED IN SERUM' [patent_app_type] => utility [patent_app_number] => 11/721106 [patent_app_country] => US [patent_app_date] => 2005-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40595 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028326.pdf [firstpage_image] =>[orig_patent_app_number] => 11721106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9238682 [patent_doc_number] => 08603471 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-10 [patent_title] => 'Methods and compositions for preventing the onset of type 1 diabetes' [patent_app_type] => utility [patent_app_number] => 11/290070 [patent_app_country] => US [patent_app_date] => 2005-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20510 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11290070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5520904 [patent_doc_number] => 20090028885 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-29 [patent_title] => 'CITRULLINE PEPTIDES DERIVED FROM FIBRIN AND RECOGNIZED BY RHEUMATOID ARTHRITIS SPECIFIC AUTOANTIBODIES, AND THE USE THEREOF' [patent_app_type] => utility [patent_app_number] => 11/577674 [patent_app_country] => US [patent_app_date] => 2005-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6128 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20090028885.pdf [firstpage_image] =>[orig_patent_app_number] => 11577674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5743095 [patent_doc_number] => 20060088820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Detecting superantigen activity in a biological sample' [patent_app_type] => utility [patent_app_number] => 11/261673 [patent_app_country] => US [patent_app_date] => 2005-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 25960 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088820.pdf [firstpage_image] =>[orig_patent_app_number] => 11261673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7987211 [patent_doc_number] => 08075899 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-12-13 [patent_title] => 'Peptides of the A-chain of proinsulin or insulin' [patent_app_type] => utility [patent_app_number] => 11/572232 [patent_app_country] => US [patent_app_date] => 2005-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18657 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/075/08075899.pdf [firstpage_image] =>[orig_patent_app_number] => 11572232 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6489336 [patent_doc_number] => 20100009462 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'Timp-2 as target/marker of beta cell failure' [patent_app_type] => utility [patent_app_number] => 11/658517 [patent_app_country] => US [patent_app_date] => 2005-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8382 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20100009462.pdf [firstpage_image] =>[orig_patent_app_number] => 11658517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7225310 [patent_doc_number] => 20050255099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Antigenic fusion protein carrying Galalpha 1,3Gal epitopes' [patent_app_type] => utility [patent_app_number] => 11/153082 [patent_app_country] => US [patent_app_date] => 2005-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10050 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20050255099.pdf [firstpage_image] =>[orig_patent_app_number] => 11153082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5101768 [patent_doc_number] => 20070185030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Immune response suppressor and treatment of multiple sclerosis' [patent_app_type] => utility [patent_app_number] => 11/570221 [patent_app_country] => US [patent_app_date] => 2005-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13961 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20070185030.pdf [firstpage_image] =>[orig_patent_app_number] => 11570221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7178895 [patent_doc_number] => 20050204415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Methods of blocking tissue destruction by autoreactive T cells' [patent_app_type] => utility [patent_app_number] => 11/129080 [patent_app_country] => US [patent_app_date] => 2005-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12086 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20050204415.pdf [firstpage_image] =>[orig_patent_app_number] => 11129080 [rel_patent_id] =>[rel_patent_doc_number] =>)